Mini Review
Accepted on 22 Jan 2026
Silent Invaders: The Role of MPs on Epithelium Inflammation and Damage in Airway Diseases
in Asthma
Frontiers in Allergy
- 178 views
- Frontiers in Allergy
- Asthma
- Articles
Type at least 3 characters
129 articles
articles
Clinical Trial
Published on 21 Jan 2026
A randomized, double-blind, placebo-controlled trial of soluble corn fiber supplementation for children with asthma
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1707834
- 457 views
Editorial
Published on 21 Jan 2026
Editorial: Exploring the interconnection: obesity's role in asthma development and management
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1759789
- 369 views
Case Report
Published on 21 Jan 2026
Case Report: Extending dosing intervals of biologics in adults severe asthma: a case series
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1635540
- 509 views
Original Research
Accepted on 20 Jan 2026
EGFR inhibitors suppress house dust mite allergen Der pII induced inflammation in monocytes and macrophages
in Asthma
Frontiers in Allergy
Review
Published on 20 Jan 2026
Biologic therapies for severe pediatric asthma: efficacy, safety, and biomarker-guided selection
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2026.1757445
- 511 views
Original Research
Accepted on 19 Jan 2026
The association between impulse oscillometry Z-scores and asthma control and exacerbation risk in a tertiary severe asthma clinic
in Asthma
Frontiers in Allergy
Original Research
Accepted on 19 Jan 2026
Pentraxin 3 Deficiency Exacerbates Neutrophilic Inflammation and Airway Hyperresponsiveness in Type 2-Low Asthma
in Asthma
Frontiers in Allergy
- 196 views
Review
Published on 12 Jan 2026
Endotype-driven decisions in choosing a biologic for airway diseases
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1754173
- 720 views
Review
Published on 09 Jan 2026
Using biomarkers and independent predictors of therapy response to optimize treatment of uncontrolled severe asthma in the biologic era
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1719820
- 688 views
Review
Accepted on 05 Jan 2026
Understanding disease burden, challenges in current treatment strategies and call for action for management of severe asthma in Asia: A position statement from Asian respiratory experts
in Asthma
Frontiers in Allergy
- 188 views
Original Research
Published on 15 Dec 2025
Real-world retrospective study on the efficacy and safety of anti-IgE therapy combined with rush immunotherapy in allergic asthma
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1717446
- 837 views
Original Research
Published on 05 Dec 2025
Association between social phobia and allergic asthma in adolescents
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1698470
- 1,389 views
Review
Published on 02 Dec 2025
Potential of alarmin-targeted bispecific and combination therapies in airway disease
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1700060
- 2,589 views
Review
Published on 25 Nov 2025
Corticosteroid insensitivity in obese asthma: potential mechanisms and therapeutic perspectives
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1719900
- 1,428 views
Original Research
Published on 24 Nov 2025
Parent-identified opportunities for improving asthma care for children insured by Medicaid following implementation of statewide Medicaid Accountable Care Organizations in Massachusetts
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1695447
- 801 views
Systematic Review
Published on 20 Nov 2025
Thymic stromal lymphopoietin expression in different biological specimens in asthma: a systematic review and meta-analysis
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1703989
- 1,188 views
Review
Published on 14 Nov 2025
Key role of thymic stromal lymphopoietin as a molecular target for biologic treatment of severe asthma
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1671353
- 2,395 views
Brief Research Report
Published on 30 Oct 2025
Allergen immunotherapy for the control of moderate to severe allergic asthma: an evidence-based conjoint analysis to define candidate patient profiles in Spain and Portugal
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1676399
- 1,984 views
Review
Published on 30 Oct 2025
Promoting immune defensive responses of epithelial cells in airway disease
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1697194
- 2,294 views
Review
Published on 15 Oct 2025
Epithelial-derived cytokines in the pathogenesis of severe asthma
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1681147
- 3,185 views
- 2 citations
Original Research
Published on 13 Oct 2025
Use of oral corticosteroids in patients with asthma: how far is clinical practice from the guidelines? Results from surveys of patients and doctors
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1638304
- 1,877 views
- 1 citation
Original Research
Published on 24 Sep 2025
From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1645968
- 2,024 views
Correction
Published on 23 Sep 2025
Correction: Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control study
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1683768
- 1,677 views